Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
基本信息
- 批准号:10084061
- 负责人:
- 金额:$ 38.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-19 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP HydrolysisAcuteAddressAdenosine TriphosphateAffectAgeAnnexinsBinding ProteinsBiochemicalBioenergeticsBiologicalBlood flowCellsChargeClinicalCompartment syndromesCoronary OcclusionsDataDevelopmentDistalDropsDyesEnsureEvans blue stainExhibitsExperimental DesignsExposure toFlexorFree EnergyGenerationsGenesGeneticGlycogenGoalsGrantHemorrhageHindlimbHourHumanHypoxiaIschemiaLimb structureLongevityMaintenanceMembraneMetabolicModelingMolecularMuscleMuscle functionMyoblastsMyocardiumMyopathyNecrosisOxygenPathologyPatientsPeripheralPeripheral arterial diseasePhenotypePhysiologicalPlayPre-Clinical ModelPredispositionProductionProteinsProteomicsReactionRegulationResistanceRoleSLC2A1 geneSarcolemmaSiteSkeletal MuscleSoleus MuscleSystemTherapeuticTissue SurvivalTissuesWalkingartery occlusionbasedesignexcitotoxicityexperienceexperimental studyextensor digitorumfemoral arteryfunctional independencegain of functionimprovedin vivoischemic injurylimb injurylimb ischemialoss of functionmortalitymouse modelnew therapeutic targetnovelnovel therapeutic interventionpreservationpreventskeletal muscle wastingtherapeutic target
项目摘要
Abstract/Project Summary
Dogma tells us that oxygen (O2) is an absolute requirement for cell/tissue survival. We have recently
discovered a unique skeletal muscle that is remarkably and uniquely resistant to negative effects of ischemia.
The implication is that unlike other peripheral skeletal muscles, this muscle has a distinct mechanism that
allows it to tolerate ischemic conditions. Identifying the underlying mechanism(s) that explain the ischemia
resistance could hold the key to unlocking therapeutic targets and/or approaches for improving tissue survival
under conditions where O2 exposure is limiting. Ischemia affects skeletal muscle in numerous clinical
conditions, including various myopathies, peripheral artery disease (PAD), compartment syndrome, severe
limb injury, etc., not to mention coronary occlusion in cardiac muscle. Thus, the identification of a mechanism
that provides ischemia resistance would overcome one of the longest standing challenges faced by clinicians.
Using an integrative experimental design, the scientific goal of this project is to elucidate the unique
functional, metabolic, and/or bioenergetic systems that account for the ability of this muscle to survive ischemic
insults. The long-term goal of the project is to leverage the identified mechanism(s) to therapeutically treat
and/or prevent myopathies induced or exacerbated by ischemia. The proposal will use molecular, biochemical,
and physiological approaches designed to address hypotheses grounded in the idea that this unique muscle
must be able to meet energetic demands and ensure sarcolemmal stability during ischemia. Thus, the
experimental approach seeks to leverage already identified genes that are critical to the generation of
adenosine triphosphate and manipulate genes that are able to stabilize the sarcolemma during ischemic
conditions to prevent excitotoxicity. Using gain-of or loss-of function approaches the experiments designed in
the proposal will determine if the mechanism is necessary for ischemia survival and also assess if the
mechanism is sufficient to survive ischemia. Completion of this proposal will challenge dogma concerning our
understanding of how tissue can resist ischemic insults and advance the field forward in a significant fashion
due to the identification of an ischemia-resistant muscle.
摘要/项目摘要
教条告诉我们,氧气 (O2) 是细胞/组织生存的绝对必要条件。我们最近有
发现了一种独特的骨骼肌,它能够显着且独特地抵抗缺血的负面影响。
这意味着与其他外周骨骼肌不同,这种肌肉具有独特的机制
使其能够耐受缺血条件。确定解释缺血的潜在机制
耐药性可能是解锁治疗靶点和/或改善组织存活的方法的关键
在 O2 暴露受到限制的条件下。缺血在许多临床中都会影响骨骼肌
疾病,包括各种肌病、外周动脉疾病(PAD)、筋膜室综合征、严重
肢体损伤等,更不用说心肌冠状动脉闭塞了。因此,识别一个机制
提供抗缺血能力将克服临床医生面临的长期挑战之一。
该项目的科学目标是采用综合实验设计来阐明独特的
功能、代谢和/或生物能量系统,解释了该肌肉在缺血状态下存活的能力
侮辱。该项目的长期目标是利用已确定的机制来治疗
和/或预防由缺血引起或加剧的肌病。该提案将利用分子、生物化学、
和生理学方法旨在解决基于这种独特肌肉的假设
必须能够满足能量需求并确保缺血期间肌膜的稳定性。因此,
实验方法旨在利用已经确定的基因,这些基因对于产生
三磷酸腺苷并操纵能够在缺血期间稳定肌膜的基因
防止兴奋性中毒的条件。使用功能增益或功能丧失方法设计的实验
该提案将确定该机制对于缺血生存是否必要,并评估是否
机制足以在缺血中生存。完成这项提案将挑战有关我们的教条
了解组织如何抵抗缺血性损伤并以重大方式推动该领域向前发展
由于抗缺血肌肉的识别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ESPEN E SPANGENBURG其他文献
ESPEN E SPANGENBURG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ESPEN E SPANGENBURG', 18)}}的其他基金
Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
- 批准号:
10242213 - 财政年份:2020
- 资助金额:
$ 38.28万 - 项目类别:
Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
- 批准号:
10897684 - 财政年份:2020
- 资助金额:
$ 38.28万 - 项目类别:
BRCA1 is necessary for optimal skeletal muscle function
BRCA1 对于最佳骨骼肌功能是必需的
- 批准号:
9753702 - 财政年份:2015
- 资助金额:
$ 38.28万 - 项目类别:
BRCA1 is necessary for optimal skeletal muscle function
BRCA1 对于最佳骨骼肌功能是必需的
- 批准号:
8886653 - 财政年份:2015
- 资助金额:
$ 38.28万 - 项目类别:
The role of BRCA1 in regulation of lipid metabolism in skeletal muscle
BRCA1在骨骼肌脂质代谢调节中的作用
- 批准号:
8286172 - 财政年份:2011
- 资助金额:
$ 38.28万 - 项目类别:
The role of BRCA1 in regulation of lipid metabolism in skeletal muscle
BRCA1在骨骼肌脂质代谢调节中的作用
- 批准号:
8112903 - 财政年份:2011
- 资助金额:
$ 38.28万 - 项目类别:
Regulation of skeletal alpha actin expression during mu*
mu* 期间骨骼 α 肌动蛋白表达的调节
- 批准号:
7031397 - 财政年份:2006
- 资助金额:
$ 38.28万 - 项目类别:
Regulation of skeletal alpha actin expression during mu*
mu* 期间骨骼 α 肌动蛋白表达的调节
- 批准号:
7434515 - 财政年份:2006
- 资助金额:
$ 38.28万 - 项目类别:
Regulation of skeletal alpha actin expression during mu*
mu* 期间骨骼 α 肌动蛋白表达的调节
- 批准号:
7198071 - 财政年份:2006
- 资助金额:
$ 38.28万 - 项目类别:
Leukemia inhibitor factor in skeletal muscle regrowth
骨骼肌再生中的白血病抑制因子
- 批准号:
6622314 - 财政年份:2002
- 资助金额:
$ 38.28万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy
靶向能量药物以改善肥厚型心肌病的预后
- 批准号:
10687401 - 财政年份:2022
- 资助金额:
$ 38.28万 - 项目类别:
Regulation of lipid metabolism in pulmonary Type 2 cells
肺2型细胞脂质代谢的调节
- 批准号:
10367413 - 财政年份:2021
- 资助金额:
$ 38.28万 - 项目类别:
Regulation of lipid metabolism in pulmonary Type 2 cells
肺2型细胞脂质代谢的调节
- 批准号:
10542430 - 财政年份:2021
- 资助金额:
$ 38.28万 - 项目类别:
Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
- 批准号:
10242213 - 财政年份:2020
- 资助金额:
$ 38.28万 - 项目类别:
Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
- 批准号:
10897684 - 财政年份:2020
- 资助金额:
$ 38.28万 - 项目类别: